Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-01-20

Clinical Trial Update: Intensity-modulated Radiation Therapy Combined With Cisplatin or Nedaplatin Chemotherapy in Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

This document reports a Phase 2 clinical trial assessing the combination of intensity-modulated radiation therapy with cisplatin or nedaplatin chemotherapy for …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CISPLATIN (cisplatin)
  • Nedaplatin (nedaplatin)

Snippet

Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: UNKNOWN